Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= targeted therapy
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(36)
+
-
Availability
Open access
(23)
+
-
Some under embargo
(1)
+
-
Under embargo
(1)
+
-
Metadata Only
(12)
+
-
Creation Date
2021
(6)
+
-
2023
(6)
+
-
2020
(5)
+
-
2019
(4)
+
-
2022
(4)
+
-
2013
(3)
+
-
2015
(3)
+
-
2017
(2)
+
-
2024
(2)
+
-
Show more
Faculty
Faculty of Science
(1)
+
-
Leiden University Medical Center (LUMC)
(29)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(29)
+
-
Scholarly Publications
(7)
+
-
Topic
targeted therapy
(37)
+
-
melanoma
(9)
+
-
immunotherapy
(7)
+
-
immune checkpoint inhibitors
(3)
+
-
metastasis
(3)
+
-
survival
(3)
+
-
AKT
(2)
+
-
BRAF mutation
(2)
+
-
ESCAT
(2)
+
-
ESMO Clinical Practice Guideline (CPG)
(2)
+
-
ESMO-MCBS
(2)
+
-
advanced melanoma
(2)
+
-
cell signaling
(2)
+
-
chemotherapy
(2)
+
-
humans
(2)
+
-
prospective nation-wide data
(2)
+
-
real-world data
(2)
+
-
treatment
(2)
+
-
tumor microenvironment
(2)
+
-
tyrosine kinase inhibitor
(2)
+
-
Show more
Author
Kapiteijn, E.
(13)
+
-
Eertwegh, A.J.M. van den
(9)
+
-
Hospers, G.A.P.
(9)
+
-
Aarts, M.J.B.
(8)
+
-
Groot, J.W.B. de
(8)
+
-
Haanen, J.B.A.G.
(8)
+
-
Piersma, D.
(8)
+
-
Rijn, R.S. van
(8)
+
-
Wouters, M.W.J.M.
(8)
+
-
Boers-Sonderen, M.J.
(7)
+
-
Vreugdenhil, G.
(7)
+
-
Berkmortel, F.W.P.J. van den
(6)
+
-
Suijkerbuijk, K.P.M.
(6)
+
-
Veldt, A.A.M. van der
(6)
+
-
Blank, C.U.
(5)
+
-
Doorn, R. van
(4)
+
-
Gelderblom, H.
(4)
+
-
Tije, A.J. ten
(3)
+
-
Aarts, M.
(2)
+
-
Akkooi, A.C.J. van
(2)
+
-
Aydemirli, M.D.
(2)
+
-
Berkmortel, F.
(2)
+
-
Blokx, W.A.M.
(2)
+
-
Boer, M.S.D.
(2)
+
-
Dijke, P. ten
(2)
+
-
Guchelaar, H.J.
(2)
+
-
Hage, J. van der
(2)
+
-
Hendriks, L.E.
(2)
+
-
Hoeven, J.J.M. van der
(2)
+
-
Kerr, K.M.
(2)
+
-
Kooij, M. van der
(2)
+
-
Kooij, M.K. van der
(2)
+
-
Menis, J.
(2)
+
-
Meza, M. de
(2)
+
-
Mok, T.S.
(2)
+
-
Morreau, H.
(2)
+
-
Nestle, U.
(2)
+
-
Not, O.J. van
(2)
+
-
Passaro, A.
(2)
+
-
Peters, S.
(2)
+
-
Planchard, D.
(2)
+
-
Rauwerdink, D.J.W.
(2)
+
-
Reck, M.
(2)
+
-
Roepman, P.
(2)
+
-
Smit, E.F.
(2)
+
-
Solomon, B.J.
(2)
+
-
Stevense, M.
(2)
+
-
Suijkerbuijk, K.
(2)
+
-
Veldt, A. van der
(2)
+
-
Veronesi, G.
(2)
+
-
Vos, F.Y.F.L. de
(2)
+
-
Wezel, T. van
(2)
+
-
Show more
Language
en
(37)
+
-
Search results
(1 - 24 of 37)
Pages
1
2
›
››
show grid
show list
save search
The predictive value of FDG PET/CT for determining progression-free survival in advanced stage III-IV BRAF-mutated melanoma patients treated with targeted therapy
BRAF/MEK inhibitor rechallenge in advanced melanoma patients
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials
Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells
Non-oncogene-addicted metastatic non-small-cell lung cancer
Oncogene-addicted metastatic non-small-cell lung cancer
Adjuvant BRAF-MEK inhibitors versus Anti PD-1 Therapy in stage III melanoma
Application of Electronic Health Record Text Mining
Systemic therapy in advanced nodular melanoma versus superficial spreading melanoma
Systemic therapy in advanced nodular melanoma versus superficial spreading melanoma
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)
Molecular testing in metastatic basal cell carcinoma
Sex-based differences in treatment with immune checkpoint inhibition and targeted therapy for advanced melanoma
The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer
Development of randomized trials in adults with medulloblastoma - the example of EORTC 1634-BTG/NOA-23
Targeting EML4-ALK gene fusion variant 3 in thyroid cancer
Efficacy of BRAF and MEK inhibition in patients with BRAF-mutant advanced melanoma and germline CDKN2A pathogenic variants
TGF-beta signaling in liver metastasis
Age does matter in adolescents and young adults versus older adults with advanced melanoma
Healthcare costs of metastatic cutaneous melanoma in the era of immunotherapeutic and targeted drugs
Malignant pheochromocytoma and paraganglioma: management options
Intrigue
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
Pages
1
2
›
››